Literature DB >> 1080777

IgM antibody-dependent cell-mediated cytotoxicity in the Moloney sarcoma virus system: the involvement of T and B lymphocytes as effector cells.

E W Lamon, H D Whitten, H M Skurzak, B Andersson, B Lidin.   

Abstract

Antibody-dependent cell-mediated cytotoxicity in the Moloney sarcoma virus (MSV) system was analyzed with respect to the subpopulations of effector cells involved in tumor target cell destruction when IgM was used as the sensitizing antibody. With unfractionated sera from animals that had undergone regression primary MSV tumors it was found that macrophages did not contribute to the cytotoxicity induced by normal spleen cells that were syngeneic to the target cells. The IgM fraction of MSV regressor sera was found to induce cytotoxicity against the target cells by immunoadsorbent column-fractionated normal spleen cells, which were either depleted of T cells or B cells, according to the specificity of the columns. Immune IgM was also found to potentiate the activity of MSV regressor spleen cells that had been similarly fractionated. Furthermore, IgM antibody was found to induced cytotoxicity by normal spleen cells which had been depleted of either T or B cells by the appropriate antiserum (anti-T or anti-Ig) in the presence of complement and subsequent recovery of the viable cells by trysinization, filtration, and washing. However, spleen cells treated with both anti-T and anti-Ig sera simultaneously in the presence of complement and subsequet recovery of viable cells, were not induced to be cytotoxic against the IgM-coated tumor target cells. Further support oy T cells was provided by an experiment showing the induction with IgM of cytotoxicity against the target cells by normal thymocytes.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1080777

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

1.  Evidence for the presence of a receptor for IgM on the pathological cells of Sézary's syndrome.

Authors:  C P Worman; G F Burns; C R Barker
Journal:  Clin Exp Immunol       Date:  1978-03       Impact factor: 4.330

2.  Effector cell involved in cell-mediated cytotoxicity to cells infected with herpes simplex virus type 1.

Authors:  I Heron; A Moller-Larsen; K Berg
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

3.  Reactivity of sera and isolated monoclonal IgM from patients with Waldenström's macroglobulinaemia with peripheral nerve myelin.

Authors:  H Harbs; M Arfmann; E Frick; C Hörmann; U Wurster; U Patzold; E Stark; H Deicher
Journal:  J Neurol       Date:  1985       Impact factor: 4.849

4.  Selective blocking of T cell-mediated in vitro cytotoxicity to a xenogeneic tumour by anti-immunoglobulin sera.

Authors:  E S Newlands; F C Hay; I M Roitt
Journal:  Clin Exp Immunol       Date:  1978-02       Impact factor: 4.330

5.  Antibody--antigen complex stimulated lysis of non-sensitized sheep red cells by human lymphocytes. I. Requirements for IgG complexes.

Authors:  E W Fuson; M W Shaw; R A Hubbard; E W Lamon
Journal:  Clin Exp Immunol       Date:  1979-10       Impact factor: 4.330

6.  Antibody-dependent cell-mediated cytotoxicity. Effectors, signals, and mechanisms.

Authors:  E W Fuson; R A Hubbard; D G Sugantharaj; R B Andrews; M R Beard; R L Whittaker
Journal:  Surv Immunol Res       Date:  1983

7.  Cell cytotoxicity due to specific influenza antibody production in vitro after recent influenza antigen stimulation.

Authors:  S B Greenberg; H R Six; S Drake; R B Couch
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

8.  Murine T cells that lyse antibody-sensitized target cells. III. Contribution of Thy 1-Bearing cells to the lytic activity of normal spleen.

Authors:  E W Lamon; B A Pollok; A S Walia; E W Fuson; B Williams
Journal:  Immunology       Date:  1981-08       Impact factor: 7.397

9.  Separation of cell-dependent antibody (CDA) and inhibitory antibody by protein-A affinity chromatography and the effect of fractions on antibody-dependent cellular cytotoxicity (ADCC).

Authors:  N Sato; Y Yabuki; K Toh; Y Ishii; K Kikuchi
Journal:  Immunology       Date:  1979-03       Impact factor: 7.397

10.  Tuberculin and dinitrochlorobenzene (DNCB) tests in cancer patients before and after cytostatic drug therapy.

Authors:  W Weber; H P Missmahl; B Mazloumi
Journal:  Klin Wochenschr       Date:  1978-09-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.